¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"red green visual substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • visual field
    ½Ã¾ß(ãÊå¯)
  • visual field defect
    ½Ã¾ß°á¼Õ(¡­ÌÀáß).
  • visual field defect
    ½Ã¾ß°á¼Õ(¡­ÌÀáß)
  • visual field for color
    »ö½Ã¾ß(ßäãÊå¯).
  • visual focus
    ½Ã°¢ÃÊÁ¡(¡­õ¥ïÇ).
  • visual function
    ½Ã±â´É
  • visual hallucination
    ȯ½Ã
  • visual hallucination
    ȯ½Ã(ü³ãÊ).
  • visual image
    ½Ã°¢»ó
  • visual impairment
    ½Ã°¢Àå¾Ö.
  • visual impairment
    ½Ã°¢Àå¾Ö(ãÊÊÆî¡äô)
  • visual infancy
    ¿µ¾ÆÇü½Ã°¢
  • visual line
    ½Ã¼±(ãÊàÊ).
  • visual loss
    ½Ã°¢»ó½Ç, ½Ç¸í
  • visual maturity
    ¼ºÀÎÇü½Ã°¢
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
MSS Marshall-Smith syndrome; massage; Medical Superintendents' Society; Medicare Statistical System; men...
OAS old age security; oral allergy syndrome; osmotically active substance
OLS oubain-like substance
PGS peristent gross splenomegaly; Pettigrew syndrome; plant growth substance; postsurgical gastroparesis...
PLS Papillon-Lefevre syndrome; polydactyly-luxation syndrome; preleukemic syndrome; primary lateral scle...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
VAPS Visual Analogue Pain Score
VAS Visual Analogue Scale
VAS Visual Analogue Score
VDT Visual Display Terminal
VDU Visual Display Unit
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
medicinal scarlet red O-Tolylazo-o-tolylazo-beta-naphthol. An azo dye; a dark, brownish red powder, soluble in oils, fats, and chloroform, but insoluble in water; used in medicine as a vulnerary, in histology to stain fat in tissue sections and basic proteins at high pH, and in immunoelectrophoresis.
Synonym: Biebrich scarlet red, medicinal scarlet red, scharlach red, Sudan IV.
(05 Mar 2000)
cherry-red spot The ophthalmoscopic appearance of the normal choroid beneath the fovea centralis, appearing as a red spot surrounded by white retinal oedema in central artery closure or lipid infiltration in sphingolipidosis.
Synonym: Tay's cherry-red spot.
(05 Mar 2000)
cherry-red spot myoclonus syndrome <syndrome> A neuronal storage disorder in children characterised by a cherry red spot at the macula, progressive myoclonus, and easily controlled seizures; the result of sialidase deficiency. Type 1 is characterised by normal body habitus, cherry red macula, myoclonus, and normal beta-galactosidase levels; type 2 by short stature, bony abnormalities, and deficient beta-galactosidase.
Synonym: sialidosis.
(05 Mar 2000)
chlorphenol red An acid-base indicator (MW 423, pK 6.0): yellow at pH values below 5.1, red above 6.7.
(05 Mar 2000)
cholera-red reaction A test for cholera vibrio whereby the addition of 3 or 4 drops of sulfuric acid (concentrated, chemically pure) to an 18-hour-old bouillon or peptone culture of the organism produces a colour from rose-pink to claret.
(05 Mar 2000)
methyl red C15H15N3O2;a weakly acid dye used as a pH indicator (red at 4.8, yellow at 6.0); easily reduced with loss of colour, and pH readings must be made rapidly.
(05 Mar 2000)
chrome red Basic lead chromate, PbCrO4PbO.
(05 Mar 2000)
rose-red <zoology> Red as a rose; specifically, of a pure purplish red colour.
Source: Websters Dictionary
(01 Mar 1998)
phenol red <chemical> 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bisphenol s,s-dioxide. Red dye, pH indicator, and diagnostic aid for determination of renal function. It is used also for studies of the gastrointestinal and other systems.
Pharmacological action: indicators and reagents, phthalein dyes.
Chemical name: Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis-, S,S-dioxide
(12 Dec 1998)
ruthenium red <chemical> A stain used in electron microscopy for acid mucopolysaccharides on the outer surfaces of cells.
(17 Dec 1997)
concentrated human red blood corpuscle Corpuscle prepared from one or more preparations of whole human blood which are not more than 14 days old and each of which has already been directly matched with the blood of the intended recipient.
(05 Mar 2000)
Congolian red fever An acute infectious disease with fever, headache, and rash, all quite similar to, but milder than, epidemic typhus, caused by a related microoganism, rickettsia typhi (mooseri), transmitted to humans by rat fleas (xenopsylla cheopis). The animal reservoir includes rats, mice and other rodents. Murine typhus occurs sporadically worldwide but is more prevalent in congested rat-infested urban areas. Also known as endemic typhus, rat-flea typhus; urban typhus of malaya).
(12 Dec 1998)
congo red <chemical> An odourless, dark red or reddish brown powder which decomposes on exposure to acid fumes. It is used as a diagnostic aid in amyloidosis, and has been used as an antihemolytic and detoxicant.
Pharmacological action: dyes.
Chemical name: 1-Naphthalenesulfonic acid, 3,3'-((1,1'-biphenyl)-4,4'-diylbis(azo))bis(4-amino-, disodium salt
(12 Dec 1998)
cresol red <chemical> A reddish-brown powder which can be dissolved in water or alcohol that has the chemical formula of C21H18O5S. The dissolved compound has different colours depending on the pH, when the pH is 7.2 it is yellow, when the pH is 8.8 it is red, and when the pH is 2-3 it is orangish. As a result, it is used as an acid-base indicator. It is also used as a stain in the study of histology.
(09 Oct 1997)
scarlet red O-Tolylazo-o-tolylazo-beta-naphthol. An azo dye; a dark, brownish red powder, soluble in oils, fats, and chloroform, but insoluble in water; used in medicine as a vulnerary, in histology to stain fat in tissue sections and basic proteins at high pH, and in immunoelectrophoresis.
Synonym: Biebrich scarlet red, medicinal scarlet red, scharlach red, Sudan IV.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • red-baiting
    °ø»ê´ç ź¾Ð(ÀÇ)
  • red-blind
    Àû»ö¸ÍÀÇ
  • red-blooded
    ³²ÀÚ´Ù¿î;±â¿îÂù;¾¿¾¿ÇÑ
  • red-breasted
    °¡½¿ÀÌ ºÓÀº
  • red-carpet
    Á¤ÁßÇÑ;¼º´ëÇÑ;À¶¼þÇÑ 
  • red-dog
    ½ºÅ©·³¼±À» ³Ñ¾î Àü°ÝÀûÀ¸·Î °ø°ÝÇÏ´Ù
  • red-eye
    =RED-EYE SPECIAL;½Î±¸·ÁÀ§½ºÅ°(¼ú);Å丶ÅäÁÖ½º¸¦ ¼¯Àº ¸ÆÁÖ;·¹µå¾ÆÀÌ(´«ÀÌ »¡°²°Ô ³ª¿À´Â Çö»ó);ºÓÀº´«ºñ·¹¿À(red-eye vireo)
  • red-eye gravy
    ÇÜ ÁóÀ¸·Î ¸¸µç À°Áó
  • red-eye special
    ½É¾ß(¾ß°£)ºñÇàÆí
  • red-eyed
    ´«(°¡ÀåÀÚ¸®)ÀÌ »¡°£;»¡°£ ´«ÀÇ
  • red-eyer
    RED-EYE(SPECIAL)ÀÇ ÀÌ¿ëÀÚ
  • red-faced
    ¾ó±¼ÀÌ ºÓÀº;¾ó±¼À» ºÓÈù;ºÎ²ô·¯¿î;´çȲÇÑ;È­°¡ ³­
  • red-handed
    ¼ÕÀÌ »¡°£;¼ÕÀÌ ÇÇÅõ¼ºÀÌÀÇ;ÇöÇà¹üÀÇ;~ly
  • red-hot
    »õ»¡°²°Ôź;¿­·ÄÇÑ;¸÷½Ã ÈïºÐÇÑ;³ë¹ß´ë¹ßÇÑ;±ØµµÀÇ;±Ø´ÜÀÇ;ÃÖ½ÅÀÇ;¼±Á¤ÀûÀÎ;¼½½ÃÇÑ;ÈïºÐÇÑ(¿­±¤ÇÑ)»ç¶÷;°ú°ÝÇÑ ±ÞÁøÁÖÀÇÀÚ;¿©ÀÚ¸¦ µ¿¹ÝÇÏÁö ¾ÊÀº ³²ÀÚ;ÇÖµµ±×;(½Ã³ª¸óÀÌ µç)ÀÛ°í »¡°£ °úÀÚ
  • red-hot mamma
    ¹ß¶öÇÑ(È­²öÇÑ,¼½½ÃÇÑ)¿¬ÀÎ(À°Ã¼ÆÄ¹Ì³à);(1920³â°æ¿¡ Àαâ ÀÖ´ø)¾ß¼º¹Ì ÀÖ´Â ¿©ÀÚ °¡¼ö 
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á